Home › Funds › OBERWEIS ASSET MANAGEMENT INC/ › ADPT

OBERWEIS ASSET MANAGEMENT INC/ position in ADPT

ADAPTIVE BIOTECHNOLOGIES COR · Health Care

OBERWEIS ASSET MANAGEMENT INC/ reported holding 1,256,802 shares of ADPT (ADAPTIVE BIOTECHNOLOGIES COR) in its Q3 2026 13F filing — a position valued at US$36.3M, representing 0.82% of its reported portfolio and ranking #35 among its reported holdings. OBERWEIS ASSET MANAGEMENT INC/ has disclosed ADPT holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)1.26M sh
Reported value held$36.32M
Portfolio Weight0.82%
First reportedQ2 2025
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How OBERWEIS ASSET MANAGEMENT INC/'s ADPT position evolved

OBERWEIS ASSET MANAGEMENT INC/ first disclosed a stake in ADPT in Q2 2025 at 589,400 shares (US$6.9M). The position peaked in Q3 2026 at 1,256,802 shares, worth US$36.3M. Across 6 filings, OBERWEIS ASSET MANAGEMENT INC/ increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,256,802 shares valued at US$36.3M. Notable position changes include a 56% increase in Q2 2026 (shares rose 35% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 589.40K $6.87M New
Q3 2025 726.50K $10.87M Add
Q4 2025 744.50K $12.09M Add
Q1 2026 806.95K $11.20M Add
Q2 2026 1.26M $27.00M Add
Q3 2026 1.26M $36.32M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ADPT and 13F data

ADPT (ADAPTIVE BIOTECHNOLOGIES COR) is a Health Care company. 58 other funds we track also report a position in ADPT — the largest reported positions include Viking Global Investors (US$643.4M), VIKING GLOBAL INVESTORS LP (US$643.4M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$136.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ADPT

All ADPT fund holders →

FAQ

How long has OBERWEIS ASSET MANAGEMENT INC/ held ADPT?

OBERWEIS ASSET MANAGEMENT INC/ has disclosed ADPT holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is OBERWEIS ASSET MANAGEMENT INC/'s current position in ADPT?

As of Q3 2026, OBERWEIS ASSET MANAGEMENT INC/ holds 1.26M shares of ADPT (ADAPTIVE BIOTECHNOLOGIES COR), valued at $36.32M, representing 0.82% of its reported portfolio and ranking #35.

Has OBERWEIS ASSET MANAGEMENT INC/ been buying or selling ADPT?

In the latest 13F filing (Q3 2026), OBERWEIS ASSET MANAGEMENT INC/ held unchanged its position in ADPT. The position peaked in Q3 2026 at 1.26M shares.

Which other funds hold ADPT?

Other major institutional holders of ADPT include Viking Global Investors, VIKING GLOBAL INVESTORS LP, DRIEHAUS CAPITAL MANAGEMENT LLC, among 58 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.